Recruiting

Robotic Assisted Bronchoscopic Ablation

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT06840288

Conditions

Thoracic Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.

Conditions

Thoracic Tumors

Study ID

NCT06840288

Start date

Feb 19, 2025

Status verified date

Jun, 2026

Completion date

Dec 31, 2036

Anticipated

Primary completion date

Dec 31, 2034

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Patients with peripheral lung tumors (primary or metastatic) that have been or will be ablated via robotic bronchoscopy.

Exclusion Criteria:

Patients with planned bronchoscopic ablations of peripheral lung tumors that were aborted for technical reasons (ablation was not completed).

Study Design

Enrollment

250 participants

Anticipated

Interventions and Outcome Measures

Arms

Small Thoracic Tumors

Primary outcome measure

  • To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors. [ Time Frame: Through study completion, an average of 1 year. ]

Central Contacts and Locations

Central contacts

Roberto F Casal, MD

(713) 792-6238rfcasal@mdanderson.org

Locations

MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Roberto F Casal, MD

713-792-6238rfcasal@mdanderson.org

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Jun 12, 2026

Last verified

Jun, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-06-12.